Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#21 / 200 Total
REBN - Reborn Coffee Inc - Stock Price Chart
TickerREBN [NASD]
CompanyReborn Coffee Inc
CountryUSA
IndustryRestaurants
Market Cap3.12MEPS (ttm)-2.56
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.62EPS next 5Y-
P/B1.31EPS Q/Q19.34%
Dividend-Sales Q/Q80.65%
Insider Own53.06%Inst Own0.14%
Insider Trans0.00%Inst Trans-
Short Float6.03%EarningsMar 28/b
Analyst Recom1.00Target Price16.00
Avg Volume115.14K52W Range0.92 - 8.80
Reborn Coffee, Inc. engages in the franchise of retail locations and kiosks of coffee, water, and other beverages. The company was founded by Jay Kim on July 31, 2015 and is headquartered in Brea, CA.
SGE - Strong Global Entertainment Inc - Stock Price Chart
TickerSGE [AMEX]
CompanyStrong Global Entertainment Inc
CountryUSA
IndustryComputer Hardware
Market Cap11.58MEPS (ttm)0.10
P/E14.45EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.23EPS next 5Y-
P/B1.24EPS Q/Q-96.09%
Dividend-Sales Q/Q10.27%
Insider Own78.01%Inst Own0.17%
Insider Trans0.02%Inst Trans-
Short Float0.55%EarningsNov 09/a
Analyst Recom-Target Price-
Avg Volume6.17K52W Range1.02 - 4.35
Strong Global Entertainment, Inc. manufactures and distributes large format project screen & coatings. It also distribute digital cinema equipment and provide technical support services to the entertainment industry. Its key markets include the cinema exhibition industry, theme parks, schools, museums, networks and other entertainment-related markets. The company was founded on November 9, 2021 and is headquartered in Charlotte, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roberson Mark D.CEO and DirectorDec 11 '23Buy1.4350071520,950Dec 12 04:05 PM
Roberson Mark D.CEO and DirectorDec 08 '23Buy1.418001,12920,450Dec 12 04:05 PM
IPHA - Innate Pharma ADR - Stock Price Chart
TickerIPHA [NASD]
CompanyInnate Pharma ADR
CountryFrance
IndustryBiotechnology
Market Cap232.82MEPS (ttm)-0.10
P/E-EPS this Y-463.48%
Forward P/E-EPS next Y82.74%
PEG-EPS past 5Y-
P/S4.15EPS next 5Y-
P/B3.67EPS Q/Q84.65%
Dividend-Sales Q/Q112.72%
Insider Own-Inst Own0.16%
Insider Trans-Inst Trans-1.00%
Short Float-EarningsMar 21/b
Analyst Recom1.29Target Price7.76
Avg Volume9.95K52W Range1.81 - 3.57
Innate Pharma SA is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Its product pipeline include Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Herve Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournie, and Francois Romagne on September 23, 1999 and is headquartered in Marseille, France.
IBIO - iBio Inc - Stock Price Chart
TickerIBIO [AMEX]
CompanyiBio Inc
CountryUSA
IndustryBiotechnology
Market Cap14.13MEPS (ttm)-26.22
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y32.72%
P/S282.58EPS next 5Y-
P/B1.43EPS Q/Q93.53%
Dividend-Sales Q/Q-
Insider Own0.39%Inst Own7.22%
Insider Trans-51.42%Inst Trans3.90%
Short Float1.71%Earnings-
Analyst Recom3.00Target Price20.00
Avg Volume2.85M52W Range1.02 - 49.80
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. It focuses on the development of precision antibodies. The company was founded on April 17, 2008 and is headquartered in Bryan, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brenner MartinSee RemarksNov 01 '23Sale0.274,8811,296182,502Nov 03 04:01 PM
Brenner MartinSee RemarksOct 03 '23Sale0.305,2671,592187,383Oct 05 04:01 PM
Brenner MartinSee RemarksOct 02 '23Sale0.314,2151,311192,650Oct 03 04:01 PM
Brenner MartinSee RemarksAug 28 '23Sale0.315,0111,529196,865Aug 30 04:22 PM
Brenner MartinSee RemarksJul 27 '23Sale0.514,5152,308201,876Jul 28 04:01 PM
CASI - CASI Pharmaceuticals Inc - Stock Price Chart
TickerCASI [NASD]
CompanyCASI Pharmaceuticals Inc
CountryChina
IndustryBiotechnology
Market Cap48.09MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-9.64%
P/S-EPS next 5Y-
P/B-EPS Q/Q47.74%
Dividend-Sales Q/Q26.48%
Insider Own56.99%Inst Own2.08%
Insider Trans0.00%Inst Trans-9.21%
Short Float2.22%EarningsMar 28/b
Analyst Recom1.00Target Price12.00
Avg Volume204.57K52W Range1.71 - 8.48
CASI Pharmaceuticals, Inc. engages in developing and commercializing therapeutics and pharmaceutical products. The company was founded in 1991 and is headquartered in Beijing, China.
FENG - Phoenix New Media Ltd ADR - Stock Price Chart
TickerFENG [NYSE]
CompanyPhoenix New Media Ltd ADR
CountryChina
IndustryInternet Content & Information
Market Cap10.71MEPS (ttm)-1.22
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-8.61%
P/S0.11EPS next 5Y5.29%
P/B0.14EPS Q/Q-80.76%
Dividend-Sales Q/Q-6.86%
Insider Own0.25%Inst Own15.74%
Insider Trans0.00%Inst Trans-10.20%
Short Float0.73%Earnings-
Analyst Recom1.00Target Price14.19
Avg Volume58.74K52W Range1.10 - 4.14
Phoenix New Media Ltd. is engaged in the provision of media and advertising services through internet, mobile, and television channels. It also provides mobile internet and value-add, and video value-added services. It operates under the Net Advertising Services and Paid Services. The company was founded in 1998 and is headquartered in Beijing, China.
MULN - Mullen Automotive Inc - Stock Price Chart
TickerMULN [NASD]
CompanyMullen Automotive Inc
CountryUSA
IndustryAuto Manufacturers
Market Cap34.06MEPS (ttm)-2356.61
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y44.05%
P/S92.05EPS next 5Y-
P/B0.15EPS Q/Q99.75%
Dividend-Sales Q/Q-
Insider Own1.68%Inst Own11.71%
Insider Trans0.00%Inst Trans-
Short Float14.45%Earnings-
Analyst Recom-Target Price5.17
Avg Volume909.40K52W Range4.11 - 3489.75
Mullen Automotive Inc. operates as an electric vehicle company, which engages in the manufacture of passenger electric vehicles and commercial vehicles. It operates through the Bollinger and Mullen/ELMS segments. The company was founded by David Michery on April 20, 2010 and is headquartered in Brea, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Michery DavidCEO, PresidentAug 16 '23Buy0.98102,040100,4281,322,083Aug 17 06:11 AM
CELC - Celcuity Inc - Stock Price Chart
TickerCELC [NASD, RUT]
CompanyCelcuity Inc
CountryUSA
IndustryBiotechnology
Market Cap522.72MEPS (ttm)-2.70
P/E-EPS this Y-5.51%
Forward P/E-EPS next Y-13.68%
PEG-EPS past 5Y-29.52%
P/S-EPS next 5Y29.00%
P/B3.94EPS Q/Q4.98%
Dividend-Sales Q/Q-
Insider Own43.02%Inst Own53.19%
Insider Trans-0.25%Inst Trans7.56%
Short Float14.55%EarningsMar 27/a
Analyst Recom1.00Target Price25.75
Avg Volume212.73K52W Range8.39 - 18.95
Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Buller Richard EDirectorFeb 21 '24Sale14.153504,9528,081Feb 23 04:43 PM
Buller Richard EDirectorDec 20 '23Sale14.373505,0308,431Dec 22 04:09 PM
Dalvey DavidDirectorDec 15 '23Sale14.572,94042,847225,000Dec 18 04:43 PM
Dalvey DavidDirectorDec 14 '23Sale14.755,00073,752227,940Dec 18 04:43 PM
Dalvey DavidDirectorDec 13 '23Sale14.505,00072,500232,940Dec 14 06:05 PM
IMRX - Immuneering Corp - Stock Price Chart
TickerIMRX [NASD, RUT]
CompanyImmuneering Corp
CountryUSA
IndustryBiotechnology
Market Cap84.62MEPS (ttm)-1.89
P/E-EPS this Y-0.20%
Forward P/E-EPS next Y-2.02%
PEG-EPS past 5Y-57.97%
P/S-EPS next 5Y-
P/B0.93EPS Q/Q-2.73%
Dividend-Sales Q/Q-100.00%
Insider Own28.20%Inst Own55.17%
Insider Trans-7.94%Inst Trans-2.76%
Short Float12.44%EarningsMar 01/b
Analyst Recom1.89Target Price15.00
Avg Volume538.74K52W Range1.90 - 14.29
Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Feinberg PeterDirectorMar 22 '24Buy2.5525,00063,713111,766Mar 25 09:13 AM
Brakewood Harold EugeneChief Business OfficerMar 22 '24Buy2.573,90010,0153,900Mar 25 09:10 AM
Schall Thomas J.DirectorMar 22 '24Buy2.552,9007,3852,900Mar 25 04:03 PM
Morales MalloryChief Accounting OfficerMar 22 '24Buy2.553931,0008,278Mar 25 09:04 AM
Morales MalloryChief Accounting OfficerMar 21 '24Buy2.721,1073,0097,885Mar 25 09:04 AM
CRVO - CervoMed Inc - Stock Price Chart
TickerCRVO [NASD]
CompanyCervoMed Inc
CountryUSA
IndustryBiotechnology
Market Cap143.76MEPS (ttm)-8.26
P/E-EPS this Y-5.93%
Forward P/E-EPS next Y-76.92%
PEG-EPS past 5Y65.00%
P/S93.96EPS next 5Y-
P/B13.81EPS Q/Q66.11%
Dividend-Sales Q/Q-
Insider Own44.63%Inst Own5.29%
Insider Trans0.00%Inst Trans-3.11%
Short Float0.54%EarningsNov 13/b
Analyst Recom1.00Target Price50.00
Avg Volume27.62K52W Range4.14 - 26.38
CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in 2001 and is headquartered in Boston, MA.
123456781020